CPA
LH icon

Capital Performance Advisors’s Labcorp LH Stock Holding History

Capital Performance Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-297
Closed -$66.4K – 1538
2024
Q3 		$66.4K Buy
+297
New +$65.3K 0.02% 278

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Capital Performance Advisors's LH Position: Q4 2024 in Review

Capital Performance Advisors sold out of Labcorp (LH) in Q4 2024, closing a stake of 297 shares — an estimated $66.4K sold.

Capital Performance Advisors first reported a position in LH in Q3 2024 and held it in 1 quarter. The position peaked at $66.4K in Q3 2024. 923 funds tracked by Wall St. Rank hold LH as of Q4 2024.

  • Capital Performance Advisors reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 297 Labcorp shares in Q4 2024, an estimated $66.4K.
  • Capital Performance Advisors first reported a position in Labcorp in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Labcorp position peaked at $66.4K in Q3 2024.
  • 923 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.